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The value of image processing and fusion has been 
investigated for diagnostic and prognostic purposes; still 
it has been a less studied tool for interventional radiologi-
cal procedures. Registration and fusion of radiological 
images is by no means a new post processing technique 
[1–5]. There are numerous technical approaches de-
scribed to coalesce imaging data from different modali-
ties [6–8] and use them to provide better health care for 
the patient. Registration is defined as aligning the two 
imaging data sets spatially to each other. While fusion is 
defined as overlaying them and visualizing them as one 
image. Algorithms for registration of anatomical and 
functional data sets have been mostly studied in fixed 
or rigid organs such as the spine or brain [2, 4, 7, 9, 10]. 
But registration is somewhat more difficult in region with 
physiologic movements like the neck [11] or in moving 
organs such as lungs [12, 13]. Major cha llenges due to 
physiologic motion and the non-rigid nature of organs 
have limited the practical implementation of image fusion 
for abdominal interventional procedures for diagnostic 
and prognostic reasons. 
Recent studies have shown that fusion of abdominal 
images from different modalities can improve diagnosis 
and monitoring of disease progression [14–16]. New 
hybrid-imaging systems combining positron emission 
tomography (PET) or single photon emission computed 
tomography (SPECT) with computed tomography (CT) 
offer a one-stop examination promoting the diagnostic 
and prognostic potentials for extra-cranial applications of 
image fusion in cancer [17–21]. Image fusion has proven 
useful for evaluation of patients with cancer suppor ting 
diagnosis, staging, treatment planning, monitoring the 
response to therapy including disease progression 
[22]. Minimally invasive image-guided therapy like ra-
diofrequency thermal ablation is being routinely used, 
especially in the liver, lung, bone and kidney [23–26] and 
improves survival for certain patients [27].
Optimal outcomes of percutaneous radiofrequency 
ablation (RFA) are highly dependent upon accurate tar-
geting of the neoplastic tissue and monitoring of the re-
sulting thermal lesion. Success of treatment is intimately 
linked to the volumetric spatial relationship of neoplastic 
tissue to the thermal lesion margins. An accurate spatial 
understanding of this relationship that is readily acces-
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sible may provide feedback du ring pre-treatment plan-
ning, procedural navigation, early detection of re-growth 
improving prognosis. Ideal image guidance for RFA al-
lows accurate probe placement for sphere-packing with 
sufficient overlap to avoid gaps of sub-lethal heating, 
and to treat a small margin of normal tissue beyond the 
neoplastic tissue borders. This is a challenging task and is 
prone to human error. The procedure is to be followed by 
repeated scanning and look for disease progression.
Image fusion was studied with an image processing 
software used before, during, and after RFA interven-
tions. Fusion of morphologic and functional image data 
might improve spatial appreciation and visualization of 
tumor and its relation to thermal lesion margins. 
MAtErIAL ANd MEtHOdS
All reported patients were enrolled under investiga-
tional protocols that were approved by the Investiga-
tional Review Boards (IRB) of the NIH. Written informed 
consent was obtained from all patients prior to the 
procedures. For this report patients and images were 
selected if they could demonstrate the feasibility and 
value of the presented fusion technique. 
Imaging modalities. Morphologic imaging was 
performed with and without contrast enhancement 
using CTi and Light Speed CT (GE Medical Systems, 
Milwaukee, WI) and 1.5 Tesla magnetic resonance 
imaging (MRI) (GE Medical Systems, Milwaukee, 
WI). Functional imaging included fluoro-18 labeled 
deoxyglucose (FDG)-PET (GE Medical Systems, 
Milwaukee, WI) and Dynamic Contrast enchanced 
(DCE)-MRI using the above mentioned scanner. Prior 
to RFA (pre-treatment phase) each patient underwent 
a contrast-enhanced CT. Some patients also had PET 
and contrast enhanced MRI or DCE-MRI scans. After 
the initial RFA treatment was completed, a 50–100 ml 
bolus of iodinated contrast medium was administered 
intravenously and a CT of the target organ was per-
formed (procedural phase). After two month patients 
were followed up with CT and in some cases addition-
aly with PET or DCE-MRI (Post-treatment phase). 
data flow and image post processing. Source 
data was archived on the hospital picture archive and 
communication system (PACS, Kodak, Rochester, NY) 
in the standard imaging DICOM (Digital imaging and 
communications in medicine) format (Fig. 1). Relevant 
data sets were retrieved from the PACS onto a per-
sonal computer (PC) workstation (1.4 GHz processor, 
512 MB RAM, MS Windows® 2000 Professional). 
Image fusion of morphologic and functional data was 
performed prior, during and after RFA between the same 
(intra-modality) and different modalities (inter-modality) 
(Fig. 2). Intra- and inter-modality registration was carried 
out using both semi-automated landmark-based me-
thods least squares [28], thin-plate-splines [29] and au-
tomatic voxel-similarity method, an optimized automated 
registration (OAR) [30, 31], available in the application 
MIPAV (Medical Image Processing and Visuali zation, 
National Institutes of Health, Bethesda, MD) using the 
above described workstation. Registration algorithms 
used included: 1) least-squares rigid registration, 
2) thin-plate spline elastic registration, and 3) automated 
voxel-similarity measure affine registration using either 
correlation ratio or mutual information cost functions. 
Intra-modality registration of pre- and post-treatment CT 
datasets was accomplished using an automatic affine 
(12 degrees of freedom) registration algorithm. This intra-
modality image fusion process used a correlation-ratio 
voxel-simularity cost function to guide the registration 
of the images. To enhance the visualization of two fused 
ima ges, MIPAV provides many tools that allow the user to 
independently personalize the contrast, brightness and 
lookup tables for each dataset. Adjustment and blending 
the amount each image contributes to the final combined 
display can be performed in real-time.
Fig. 1. Workflow for patients scheduled for RFA. Initial imaging 
includes morphologic and/or functional imaging. DICOM ima-
ges are sent directly or via PACS to a PC workstation for image 
registration and fusion. The results are pushed to a laptop that 
is taken into the procedure suite where patient information can 
be retrieved. During RFA, image fusion can be performed on 
the laptop, which may receive data from PACS or CT scanner. 
Follow-up morphologic and functional imaging data is later fused 
with pre-procedure imaging data on a workstation 
Fig. 2. Image fusion combines the visualization characteristics of 
malignant lesions seen with morphologic (CT, MRI) and functional 
(PET, DCE-MRI) imaging before, during, and after RFA. After 
RFA the relation and characteristics of tumor and thermal lesion 
can be assessed in a fused data set. Various combinations are 
possible, including intra-modality (e. g. pre-CT vs post-CT) or 
inter-modality (e. g. pre-CT vs pre-PET) 
Different thresholds and color lookup-tables were 
evaluated for visualization regarding the imaging 
modality and combination of data sets. Image fusion, 
volume and surface rendering including multi-planar 
visualization were performed on the same workstation 
using the above mentioned MIPAV software. 
A laptop PC (1.4 GHz processor, 512 MB RAM, Win-
dows® 2000 Professional) was used for intra-procedural 
fusions and for intra-procedural display (see Fig. 1). 
rESULtS
Fusion results varied in accuracy depending upon 
organ shift, respiratory variations, lesion or organ 
shrinkage, and positional changes. The semi-manual 
landmark methods (least squares, thin-plate splines) 
required longer setup times due to selection of landmarks 
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(~10–20 min without cropping). This was less practical for 
intra-procedural navigation, and required a trained user. 
However, applying the automated voxel-similarity affine 
registration algorithm to cropped volumes produced 
reasonable processing times, facilitating fusion during 
treatments (3–5 min with cropping). Cropping the image 
had two major advantages: first, cropping significantly 
reduced processing time and second, cropping locali-
zed the registration of the images, reducing non-linear 
distortion artifacts, thus improving the affine registration 
process. The voxel-similarity registration technique was 
the fastest and thus potentially most useful method for 
registration during treatments (Fig. 3). However, the land-
mark methods have a built-in internal control, and were 
better in selected cases for specific patients (Fig. 4, 5). 
The landmark-based elastic method (thin plate spline) 
was more accurate for registration of organ shift in some 
cases (Fig. 6). However, elastic methods alter the actual 
imaging data, and thus have potential for error. 
pre-treatment phase. The CT scans provided pri-
marily morphologic information on organ anatomy, tumor 
environment, adjacent large vasculature, and vascular 
supply (see Fig. 3; 4, a). Functional imaging by PET and 
DCE-MRI scans allowed functional lesion assessment 
of the metabolic (see Fig. 4, b) or pharmacokinetic mic-
rovascular status of the lesion (see Fig. 5, a). RFA needle 
trajectories were planned based on conventional mental 
registration, and retrospectively validated with fused ima-
ges (see Fig. 6, b; Fig. 7). In addition, fused 3D-images 
with PET or DCE-MRI confirmed or facilitated neoplastic 
targets. Volume rendering of lesions helped to under-
stand the spatial relation of the tumor and surrounding 
structures, which was not obvious from the conventional 
two-dimensional view (see Fig. 4, d). Similar fused com-
binations localized suspicious residual tumor that would 
need repeated RFA (see Fig. 5, 6, c). DCE-MRI showed 
suspicious residual untreated tumor (see Fig. 5, a), which 
was confirmed with pre treatment PET fused to pre treat-
ment CT (Fig. 5, b).
Procedural phase. Fused images especially helped 
to guide RFA in patients were CT alone could not define 
recurrent tumor (see Fig. 6, c and d) The procedural 
images were registered to the pre-treatment images. 
Fused images of pre-treatment-CT and intra-procedural 
a b
c d
Fig. 3. CT scan and elastic fusion images of kidney tumor and post-RFA thermal lesion. Contrast enhanced axial CT slices show a left 
kidney lesion before RFA (a, arrow) and thermal lesion two months after RFA (b, arrow). Due to change in kidney shape post ablation, 
elastic registration method is used to fuse pre- and post-RFA images (c and d), which defines treatment margins (dark blue)
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a b
c d
Fig. 4. Patient with metastatic pancreatic carcinoma isolated to the liver. Pre-RFA contrast enhanced axial CT slice (a) shows detailed mor-
phology with 4 possible targets (arrows) for treatment. PET (b) shows abnormal FDG uptake in 2 anterior liver lesions. Intermodality PET/CT 
fusion (c) localizes active lesions (crosshairs). Volume rendering (d) visualizes metabolic activity with 3 dimensional details
a b
Fig. 5. Patient with residual tumor following RFA for multiple liver metastases. Dynamic contrast enhanced MRI (a) compared to 
a fused PET/CT (b) confirms tumor and correlates vascular pharmacokinetics with metabolic activity 
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post-RFA CT rapidly defined adequate treatment mar-
gins well using OAR technique (see Fig. 7). 
If questionable areas are identified with possible 
residual tumor, then repeated RFA can be considered 
before the patient is removed from the room, although 
fusion was not used prospectively in our study to alter 
any treatment plan.
post-treatment phase. Conventional assessment is 
based on a visual comparison to determine whether the 
pre-treatment lesions and post-treatment areas are well 
matched (see Fig. 3, a and b). However, registered and 
fused images may provide better visualization of subtle 
diffe rences (see Fig. 3, c and d ; 7, 8, 9). Follow-up ima-
ging can be fused to pre-RFA imaging to compare tumor 
to treatment margin, however this method becomes less 
useful the longer the follow-up, given that post-RFA le-
sions will shrink with time (see Fig. 9).
Technical Results. Free network flow of DICOM 
ima ges was achieved between PACS, imaging scan-
ners and PC workstations. MIPAV provided both 
volume rendering as well as multi-planar display of 
fused images for lesion visualization with CT, MRI and 
PET datasets. Rigid (see Fig. 4; 9, a–c) and elastic 
(see Fig. 3, Fig. 9, d–f) registration methods were 
successfully applied intra-operatively but can be chal-
lenged due to organ shrinkage at follow up. Choosing 
accurate and homologous landmarks, in each of the 
volume datasets was rather time consuming, even 
more for inter modality registration e.g. PET-CT. The 
OAR method was faster and appreciated during the 
procedural phase. Cropping the image had two ma-
jor advantages; first, cropping significantly reduced 
processing time. Second, cropping localized the re-
gistration, reducing non-linear distortion artifacts, thus 
improving the affine registration process by narrowing 
the processing to the volume of interest.
dIScUSSION
Previous studies have shown that image fusion is 
a powerful methodology to enhance diagnostic and 
follow up imaging in cancer patients [30, 32–34]. 
Different registration algorithms have been used suc-
cessfully for non-interventional applications in the past 
[29, 35], and were successfully applied in this study 
a b
c d
Fig. 6. CT, MRI, and PET images of a patient with colorectal carcinoma with liver metastases. Axial CT (a) and MRI (b) slices post-RFA showing 
only morphology (arrows) appearing negative for recurrence. Retrospective off-line fusion of CT and PET data sets (c) validates a pathology-
proven residual tumor along the posterior border of the liver. Repeat treatment targeted with spatial knowledge of PET activity (d) 
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to RFA for liver and kidney tumors. Registration and 
fusion may be useful during interventional procedures 
and may assist before, during, and after RFA [21]. 
Often morphologic and functional imaging studies 
provide separate and complimentary information. 
Registration of pre- and post-RFA images may provide 
another window into the often-subtle spatial relation-
ships between tumor and post-RFA thermal lesion. 
Conventional interpretation uses mental re gistration 
[9]; however computer proces sing may provide a more 
objective and exact view [36]. Image fusion has ma-
tured predominately for rigid structures (brain and 
bone), and many technical details have already been 
refined, however, several major problems remain while 
performing image fusion after RFA.
The problem of respiratory motion is inherent to 
the imaging itself. Image fusion is easily performed 
on the brain [2] because the skull is a rigid structure 
that prohibits significant movements. Unlike the brain, 
the abdominal cavity is not stationary, and organs 
can significantly alter their shape and location. These 
changes can be due to breathing, the position of the 
patient on the table, organ shift, change in organ 
shape, hydration status, stomach contents, and the 
RFA procedure itself etc. Not surprisingly, this caused 
mis-registration and hampered the fusion process in 
the kidney and liver in some cases.
Organ shift and shrinkage were encountered, as 
thermal lesions tend to shrink after RFA. This is prob-
lematic for retrospective fusion of post-RFA images to 
a b
c d
Fig. 7. Right kidney tumor in patient with von Hipple-Lindau syndrome. Pre-RFA fused with post-RFA contrast enhanced axial CT slices (from 
superior to inferior, a–c) using optimized automated registration (OAR) method with correlation ratio voxel-similarity cost function. Images a–c 
were cropped and colo rized with MIPAV tools to speed the registration process and enhance visualization. The pre-treatment CT appears in gray 
and the post-treatment CT is in color, i. e. the yellow treatment margin (thin arrows) overlays the original grayscale tumor (thick arrows). Notice 
the thin margin (double tailed arrow) in (b) which could potentially have been a site of recurrence; however, 6 month, 1 year, and 18 months 
(d) post treatment scans showed no recurrence. Although there was a thin margin, fusion correctly depicted an adequate thermal lesion
112 Experimental Oncology 31, 106–114, 2009 (June)
pre-RFA images to assess for adequacy of treatment 
margin (see Fig. 9). If weeks to months are allowed 
to pass before post-RFA imaging, then registration 
may show the now-shrunken thermal lesion to be 
smaller than the tumor, giving the false impression of 
inadequate treatment. This occurred repeatedly when 
we compared 2-month post-RFA images to pre-RFA 
images in kidney tumor patients, who did not suffer 
subsequent recurrence years later (see Fig. 7).
The size of the safety margin may influence the 
utility of this technique [37]. In the liver, a 5–10 mm 
margin of normal tissue burned may be easier to 
mentally co-register than a patient with a familial renal 
cell carcinoma, where only a several mm margin is 
desirable, to preserve normal kidney function given 
the predisposition for synchronous and metachronous 
tumor development over a lifetime. For the latter, this 
technique may be more useful. 
If a tumor only presents during arterial phase ima-
ging, co-registration may enable using the spatial 
information of that brief arterial phase for localiza-
tion during a procedure. Image registration lets the 
physician use off-line prior imaging in the procedure 
room. Any imaging dataset can be registered to CT 
space, which can then be used to guide robotic needle 
placements for point and click tumor destruction [38]. 
a b c
Fig. 8. Patient with lesion at liver dome. Contrast enhanced axial CT slice shows low attenuation lesion adjacent to a high attenuation 
lesion (arrow) in dome of liver (a). Rigid registration of PET/CT pre-RFA shows abnormal FDG uptake over low attenuation lesion 
adjacent to high attenuation lesion (b). Post-RFA CT fused with pre-RFA PET (c) verifies RFA treatment zone with margins covering 
the area of abnormal FDG uptake (arrow)
a b c
d e f
Fig. 9. Post processed cropped and colorized CT before RFA, after RFA, and fused image using rigid and elastic registration methods. Top 
row (a–c) is rigid registration whereas the bottom row (d–f) is elastic registration. The first column (a, d) is pre-RFA CT. The second column 
(b, e) is 2 months post RFA CT scan. Rigid registration (c) matches hand picked anatomy from one image to the other without altering either 
source image. This may result in mismatch (arrow) since the organ has shifted in the time interval between imaging. Elastic registration (f) 
also uses landmarks for point-to-point registration, but allows deformation of anatomy to better match the area of interest (arrow) 
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This is a powerful tool that may gain importance in the 
future as tumor-specific and cell-specific contrast 
agents are developed. Fusion may also enable biopsy 
of metabolically active regions of a tumor, which could 
facilitate more accurate biopsy and improved informa-
tion on the temporal and spatial evolution of a tumor 
genomic or proteomic profile. This in turn could help 
tailor patient-specific drug regimens.
Region cropping proved to be a rapid and simple 
method of scaling down the large imaging datasets into 
a computationally workable size. While future optimiza-
tions are planned and processing speeds are improving, 
the registration process took 3–5 min, which makes this 
technique clinically relevant for intra-procedural moni-
toring and navigation. Monitoring and navigation during 
RFA currently suffers from imaging limitations. Ultra-
sound gas shadows the burn, CT contrast increases 
risk of renal toxicity, CT fluoroscopy has potentially high 
radiation doses to the user, and MR thermometry is not 
widely available, is costly, and requires a RF switch box 
or alternating imaging Rf-signals with treatment cur-
rents. Electromagnetic tracking during RFA may register 
pre-procedural imaging to the patient for use during 
needle manipulation and is being further investigated 
as an alternate method allowing use of pre-procedural 
imaging during interventions [39]. 
Versatile fusion software with multiple available 
methods of rigid and elastic registration may improve 
chances for optimal fusion for a given patient [40, 41], 
as each method has own inherent strengths and weak-
nesses. However, fusion can facilitate interventions in 
select scenarios. Further validation is indicated before 
these techniques can be routinely utilized or applied to 
navigation systems or treatment planning software. 
Current methods of monitoring treatment during 
RFA are inadequate and may represent the largest 
technical limitation of RFA today. Early detection of the 
tumor activity could potentially improve outcomes by 
allowing for early repeat intervention before regrowth 
results in a geometrically-unfavorable configuration.
In addition, method 1 (least squares) generates 
a rigid transformation, which involves 6 degrees of 
freedom (3 rotations and 3 translations). Method 
2 (thin plate splines) is non-linear and can provide 
a richer registration than method 1 since this method 
can address non-linear registration problems (e. g., 
breathing artifacts, organ shift, and organ deforma-
tion). However, the accuracy of these two landmark 
registration methods is sensitive to user training and 
expertise in choosing landmarks. In addition, it can be 
time consuming and difficult to find enough landmarks 
to produce and acceptable registration. 
However, the affine voxel-similarity automatic method 
is invariant to the user and often provides an acceptable 
result. This method has up to 12 degrees of freedom 
(3 rotations, 3 translations, 3 scale and 3 skew). While 
this may yield useful results, this method does not 
address breathing artifacts very well. Voxel similarity 
methods use statistics based on comparisons of voxel 
intensities between two datasets. Correlation ratio and 
cross-correlation measures are typically used to register 
intra-modality datasets. Normalized mutual information 
is typically used for inter-modality registration. Correla-
tion ratio and normalized mutual information cost func-
tions were used in this study for method 3 for intra and 
inter modality registration, respectively.
To fully visualize two fused images, it is important 
to be able to adjust the colorization or lookup tables, 
brightness, and contrast of each image independently. 
In addition, it is also important to be able to adjust the 
amount of blending between the two fused images. 
Having the ability to modify these image attributes 
greatly improves the visualization of lesions, vessels, 
and necrotic tissue. Such visualization is vital to the ac-
curate assessment of RFA safety margins (see Fig. 3 and 
Fig. 7). The most subjectively effective color schemes 
were saved, which allowed the further automation of 
routine post-processing steps. In addition, surface-
rendering techniques allowed for locali zation and the 
visual quantification of both pre-treatment lesion and 
post-treatment ablation volumes. Image processing 
and multimodality fusion are mature diagnostic tools 
that should be further evaluated for potential utility du-
ring interventional radiology procedures. 
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